Is the Ramsay Health Care share price a buy?

The Ramsay Health Care Limited (ASX: RHC) share price has just recovered from hitting its lowest level in four years – is it a buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The Ramsay Health Care Limited (ASX: RHC) share price has just recovered from hitting its lowest level in four years. After reaching an all-time high of $81.31 in September 2016, the share price (and Ramsay shareholders) have been suffering ever since. Ramsay did not come out of the recent correction unscathed, with the sell-off dragging the share price to a four-year low of $52.92 in October. It has since bounced back slightly and at the time of writing, is trading around the $58 mark.

Australia's ageing population and ever-rising demand for medical services bode well for the healthcare sector, which has been one of the strongest performers on the ASX over the past decade. Stocks such as CSL Limited (ASX: CSL) and NIB Holdings Limited (ASX: NHF) have generated stellar returns for investors during this time.

Ramsay is Australia's largest private hospital operator, with over 223 hospitals and more than 60,000 staff across several countries, with a strong and expanding presence in Europe. Ramsay has historically enjoyed strong returns on invested capital due to its ownership and management of flagship private hospitals in Australia, resulting in a reputation for high-quality care. The company's scale also enables them to negotiate very effectively with private health insurers, which gives it enormous pricing power. This has enabled Ramsay to establish a significant cost advantage, which has underpinned its successful expansion both in Australia and overseas.

So, what has gone wrong?

Ramsay is facing some difficult structural problems going into 2019. Analysts are expecting core EPS growth of only 2% for the financial year, mainly due to some recent acquisitions that are not yet bearing fruit. Furthermore, declining private health insurance memberships and high out-of-pocket hospital costs are pushing more patients into the public health system, and out of Ramsay's private hospitals, placing pressure on earnings.

However, Ramsay remains confident of its acquisitions and is planning on expanding their business into more areas into the future.

Foolish takeaway

Although Ramsay is facing some short-term headwinds, I believe the demographics of the healthcare sector, both in Australia and around the globe, provide a significant tailwind for the company. I believe Ramsay's effective management team and expansion strategy make Ramsay Health Care a great addition for any long-term investor.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited and Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A cool white-bearded man holds his hand up signalling you should halt.
Healthcare Shares

ASX 300 cannabis stock Incannex suspended ahead of 'material update'

The Incannex share price is frozen at 14 cents for now.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Guess which ASX All Ords stock is rocketing 27% on a new FDA approval

Rett Syndrome has finally got an approved treatment.

Read more »

Five healthcare workers standing together and smiling.
Healthcare Shares

Buy these excellent ASX 200 healthcare shares: Goldman Sachs

Goldman has spoken very positively about these healthcare shares this week.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Should I buy CSL shares while they're under $300?

Can investors make a healthy return with this biotech?

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.
Healthcare Shares

Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

Read more »

an older couple look happy as they sit at a laptop computer in their home.
Healthcare Shares

Hoping to collect the latest CSL dividend? Here's how

The next CSL dividend is fast approaching.

Read more »